| Yearly Results of Sun Pharmaceutical Industries (in Rs. Cr.) |
Mar '22 |
Mar '21 |
Mar '20 |
Mar '19 |
Mar '18 |
|
| Net Sales/Income from operations |
15,518.50 |
12,570.93 |
11,906.74 |
9,783.29 |
7,696.33 |
|
| Other Operating Income |
67.48 |
232.28 |
625.19 |
519.92 |
251.27 |
|
| Total Income From Operations |
15,585.98 |
12,803.21 |
12,531.93 |
10,303.21 |
7,947.60 |
|
| EXPENDITURE |
|
|
|
|
|
|
| Consumption of Raw Materials |
4,584.97 |
3,809.11 |
3,201.71 |
2,727.71 |
2,167.52 |
|
| Purchase of Traded Goods |
1,248.60 |
1,199.63 |
1,227.41 |
1,196.85 |
1,165.99 |
|
| Increase/Decrease in Stocks |
-183.18 |
-214.84 |
138.60 |
-251.30 |
159.26 |
|
| Power & Fuel |
-- |
-- |
-- |
-- |
-- |
|
| Employees Cost |
2,000.78 |
1,798.45 |
1,702.77 |
1,571.34 |
1,617.69 |
|
| Depreciation |
1,349.95 |
586.81 |
561.56 |
552.95 |
432.23 |
|
| Excise Duty |
-- |
-- |
-- |
-- |
-- |
|
| Admin. And Selling Expenses |
-- |
-- |
-- |
-- |
-- |
|
| R & D Expenses |
-- |
-- |
-- |
-- |
-- |
|
| Provisions And Contingencies |
-- |
-- |
-- |
-- |
-- |
|
| Exp. Capitalised |
-- |
-- |
-- |
-- |
-- |
|
| Other Expenses |
5,027.29 |
3,274.86 |
3,549.79 |
3,302.35 |
2,714.12 |
|
| P/L Before Other Inc. , Int., Excpt. Items & Tax |
1,557.57 |
2,349.19 |
2,150.09 |
1,203.31 |
-309.21 |
|
| Other Income |
957.92 |
150.22 |
1,510.92 |
1,271.44 |
1,128.04 |
|
| P/L Before Int., Excpt. Items & Tax |
2,515.49 |
2,499.41 |
3,661.01 |
2,474.75 |
818.83 |
|
| Interest |
388.10 |
256.98 |
408.01 |
540.92 |
388.31 |
|
| P/L Before Exceptional Items & Tax |
2,127.39 |
2,242.43 |
3,253.00 |
1,933.83 |
430.52 |
|
| Exceptional Items |
-1,820.53 |
-89.56 |
-- |
-1,214.38 |
-950.50 |
|
| P/L Before Tax |
306.86 |
2,152.87 |
3,253.00 |
719.45 |
-519.98 |
|
| Tax |
406.85 |
13.17 |
41.86 |
-97.15 |
-25.39 |
|
| P/L After Tax from Ordinary Activities |
-99.99 |
2,139.70 |
3,211.14 |
816.60 |
-494.59 |
|
| Prior Year Adjustments |
-- |
-- |
-- |
-- |
-- |
|
| Extra Ordinary Items |
-- |
-- |
-- |
-- |
-- |
|
| Net Profit/(Loss) For the Period |
-99.99 |
2,139.70 |
3,211.14 |
816.60 |
-494.59 |
|
| Equity Share Capital |
239.93 |
239.93 |
239.93 |
239.93 |
239.93 |
|
| Reserves Excluding Revaluation Reserves |
24,348.02 |
24,800.23 |
24,156.29 |
22,603.68 |
22,082.68 |
|
| Equity Dividend Rate (%) |
1,000.00 |
750.00 |
400.00 |
275.00 |
200.00 |
|
| EPS Before Extra Ordinary |
|
|
|
|
|
|
| Basic EPS |
-0.40 |
8.92 |
13.38 |
3.40 |
-2.10 |
|
| Diluted EPS |
-0.40 |
8.92 |
13.38 |
3.40 |
-2.10 |
|
| EPS After Extra Ordinary |
|
|
|
|
|
|
| Basic EPS. |
-0.40 |
8.92 |
13.38 |
3.40 |
-2.10 |
|
| Diluted EPS. |
-0.40 |
8.92 |
13.38 |
3.40 |
-2.10 |
|
| Public Share Holding |
|
|
|
|
|
|
| No Of Shares (Crores) |
-- |
-- |
-- |
-- |
-- |
|
| Share Holding (%) |
-- |
-- |
-- |
-- |
-- |
|
| Promoters and Promoter Group Shareholding |
|
|
|
|
|
|
| a) Pledged/Encumbered |
|
|
|
|
|
|
| - Number of shares (Crores) |
-- |
-- |
-- |
-- |
-- |
|
| - Per. of shares (as a % of the total sh. of prom. and promoter group) |
-- |
-- |
-- |
-- |
-- |
|
| - Per. of shares (as a % of the total Share Cap. of the company) |
-- |
-- |
-- |
-- |
-- |
|
| b) Non-encumbered |
|
|
|
|
|
|
| - Number of shares (Crores). |
-- |
-- |
-- |
-- |
-- |
|
| - Per. of shares (as a % of the total sh. of prom. and promoter group). |
-- |
-- |
-- |
-- |
-- |
|
| - Per. of shares (as a % of the total Share Cap. of the company). |
-- |
-- |
-- |
-- |
-- |
|
Source : Dion Global Solutions Limited
